AARP Launches New Tool To Help Mississippi’s Veterans Access Health Care
JACKSON, Miss., Nov. 24, 2021 /PRNewswire/ -- AARP launched a new tool to bring together valuable information and resources to help...
Month: November 2021
Aidoc Releases the First ‘AI OS’ Unifying AI Across Enterprise Imaging to Address Technical Barriers of Using AI
NEW YORK, Nov. 24, 2021 /PRNewswire/ -- Aidoc, a leading provider of artificial intelligence (AI) solutions for medical imaging, announced today...
GOOVIS Head-Mounted Displays Offer the Gift of ‘Good Vision’ This Festive Season
HONG KONG, Nov. 24, 2021 /PRNewswire/ -- As the festive season approaches, GOOVIS, an industry leader in head-mounted display (HMD)...
Waterdrop Inc. to Report Third Quarter 2021 Financial Results on November 30, 2021
BEIJING, Nov. 24, 2021 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to...
Nagarro partners with BioT to deliver best-in-class software for medical devices
DUBAI, UAE, Nov. 24, 2021 /PRNewswire/ -- Nagarro, a global digital engineering company, and BioT Medical, a No-code connected-care platform for medical devices,...
Amgen and Bushu Pharma Announce Expanded Supply Chain Partnership across Japan and Asia-Pacific Region
KAWAGOE, Japan, Nov. 24, 2021 /PRNewswire/ -- Bushu Pharmaceuticals Ltd. ("Bushu Pharma") has agreed on an expanded partnership with Amgen...
Avicanna Expands its Medical Cannabis Brand RHO Phyto into the Caribbean Region with Initial Export to Barbados
RHO Phyto Avicanna Expands its Medical Cannabis Brand RHO Phyto into the Caribbean Region Starting with 3 SKUs, the advanced...
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
NEW YORK and MAINZ, Germany, November 25, 2021—Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced...
SEI Healthcare Releases ERA-EDTA 2021 Congress Summary: Anaemia and CKD Insights
An On-Demand Webinar supported by Astellas Pharma and developed in collaboration with the European Renal Association and European Dialysis and...
Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2022 Annual General Meeting
ORION CORPORATION STOCK EXCHANGE RELEASE 25 NOVEMBER 2021 at 10.30 EET Recommendation by the Orion Nomination Committee on the...
Ultimovacs ASA: Mandatory notification for close associate
Oslo, Norway, November 25, 2021: Radforsk Investeringsstiftelse, a legal person closely associated with a person discharging managerial responsibilities in Ultimovacs...
Saniona AB’s Nomination Committee for the Annual General Meeting 2022
PRESS RELEASE November 25, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the...
Pixium Vision to present at BTIG’s Ophthalmology Day
Pixium Vision to present at BTIG’s Ophthalmology Day Paris, France, November 25, 2021 – 07.00 CET– Pixium Vision SA (Euronext...
Natural Asthma Symptom Management – AirPhysio OPEP Breathing Device Relaunched
The award-winning AirPhysio device has been relaunched on the Life Wellness Healthcare online store. The move enables those with breathing...
Supernus Pharmaceuticals Targeted in Ransomware Incident
The attack had no significant impact on the business and did not cause any significant disruption to Company’s operations No...
Overview of the deadlines at which shares of AS Olainfarm will be excluded from the regulated market:
Overview of the deadlines at which shares of AS Olainfarm will be excluded from the regulated market: The period of...
Allarity Therapeutics A/S Publishes Offer Document Offering to Acquire Company Shares in Exchange for Shares in Allarity Therapeutics, Inc. with the Intent to Complete Recapitalization
Press release Hørsholm, Denmark (November 24, 2021) — Allarity Therapeutics A/S ("Allarity A/S" or the "Company") hereby announces a voluntary...
Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 Million Private Placement From Investissement Quebec
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS...
Selecta Biosciences Provides Update on Phase 1/2 Clinical Trial of SEL-302 for the Treatment of Methylmalonic Acidemia
-U.S. FDA has issued a clinical hold on Phase 1/2 Clinical Trial of SEL-302 due to CMC related questions-WATERTOWN, Mass.,...
Grant of New Warrants and Resolutions on Existing Warrants
Company Announcement Hørsholm, Denmark (November 24, 2021) — Allarity Therapeutics A/S ("Allarity" or the "Company") today announced that the Board...